Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | yes | yes: 4 |
Forrest at al. (procyclic) | yes | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4HS19
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.641 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.459 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.452 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.384 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.631 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.657 |
DEG_SPOP_SBC_1 | 155 | 159 | PF00917 | 0.363 |
DOC_MAPK_JIP1_4 | 229 | 235 | PF00069 | 0.432 |
DOC_PP2B_LxvP_1 | 223 | 226 | PF13499 | 0.434 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.354 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.277 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.495 |
DOC_USP7_UBL2_3 | 50 | 54 | PF12436 | 0.573 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.447 |
LIG_14-3-3_CanoR_1 | 130 | 138 | PF00244 | 0.453 |
LIG_14-3-3_CanoR_1 | 59 | 69 | PF00244 | 0.645 |
LIG_eIF4E_1 | 12 | 18 | PF01652 | 0.542 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.461 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.543 |
LIG_FHA_2 | 264 | 270 | PF00498 | 0.507 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.445 |
LIG_FHA_2 | 91 | 97 | PF00498 | 0.644 |
LIG_LIR_Gen_1 | 147 | 155 | PF02991 | 0.378 |
LIG_LIR_Gen_1 | 240 | 251 | PF02991 | 0.444 |
LIG_LIR_Gen_1 | 269 | 278 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 269 | 275 | PF02991 | 0.351 |
LIG_Pex14_2 | 111 | 115 | PF04695 | 0.322 |
LIG_SH2_CRK | 22 | 26 | PF00017 | 0.483 |
LIG_SH2_PTP2 | 14 | 17 | PF00017 | 0.432 |
LIG_SH2_SRC | 12 | 15 | PF00017 | 0.456 |
LIG_SH2_SRC | 274 | 277 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.483 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.365 |
LIG_SH3_1 | 22 | 28 | PF00018 | 0.441 |
LIG_SH3_3 | 175 | 181 | PF00018 | 0.563 |
LIG_SH3_3 | 22 | 28 | PF00018 | 0.416 |
LIG_SUMO_SIM_par_1 | 194 | 200 | PF11976 | 0.387 |
LIG_TRFH_1 | 220 | 224 | PF08558 | 0.522 |
LIG_UBA3_1 | 69 | 74 | PF00899 | 0.670 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.498 |
MOD_CK1_1 | 250 | 256 | PF00069 | 0.566 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.644 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.639 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.450 |
MOD_CK2_1 | 34 | 40 | PF00069 | 0.456 |
MOD_CK2_1 | 90 | 96 | PF00069 | 0.572 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.371 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.341 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.650 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.569 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.528 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.503 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.410 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.543 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.590 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.545 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.359 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.480 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.703 |
MOD_NEK2_1 | 69 | 74 | PF00069 | 0.630 |
MOD_PIKK_1 | 234 | 240 | PF00454 | 0.374 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.590 |
MOD_PIKK_1 | 94 | 100 | PF00454 | 0.368 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.442 |
MOD_PKA_2 | 228 | 234 | PF00069 | 0.461 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.682 |
MOD_PKA_2 | 279 | 285 | PF00069 | 0.516 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.422 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.406 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.438 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.445 |
TRG_DiLeu_LyEn_5 | 16 | 21 | PF01217 | 0.458 |
TRG_ENDOCYTIC_2 | 12 | 15 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.395 |
TRG_ENDOCYTIC_2 | 243 | 246 | PF00928 | 0.446 |
TRG_ENDOCYTIC_2 | 272 | 275 | PF00928 | 0.344 |
TRG_ER_diArg_1 | 185 | 188 | PF00400 | 0.600 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.454 |
TRG_Pf-PMV_PEXEL_1 | 100 | 105 | PF00026 | 0.430 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAZ3 | Leptomonas seymouri | 51% | 85% |
A0A0S4IUM5 | Bodo saltans | 33% | 98% |
A0A1X0NMU9 | Trypanosomatidae | 42% | 100% |
A0A3R7NSA7 | Trypanosoma rangeli | 44% | 97% |
A0A3S5H589 | Leishmania donovani | 100% | 100% |
A4H3U4 | Leishmania braziliensis | 58% | 100% |
C9ZY11 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 98% |
E9AK06 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q9XZY4 | Leishmania major | 93% | 100% |
V5BA94 | Trypanosoma cruzi | 24% | 80% |
V5D9R6 | Trypanosoma cruzi | 41% | 96% |